Philip D'Arcy Hart

BMJ 2006; 333 doi: (Published 24 August 2006) Cite this as: BMJ 2006;333:449

Medical researcher who pioneered the controlled clinical trial as a gold standard and who demonstrated the efficacy of streptomycin as a treatment for tuberculosis

In a long career—he lived to 106 and worked until he was 102—Philip D'Arcy Hart showed that pneumoconiosis was an industrial disease for which sufferers should receive compensation. In a landmark controlled clinical trial with Sir Austin Bradford Hill, Hart showed that streptomycin, then newly discovered, cured tuberculosis. In 1965 he was made a CBE for this work. He did other major epidemiology, retired at 65, and spent the next 37 years making fundamental advances on the pathogenesis of tubercle bacilli.

Embedded Image


Philip Montagu D'Arcy Hart was born in London in 1900 to a wealthy, cultivated, and philanthropic family. His father trained as a barrister but abandoned the bar to become a successful painter; his mother was the daughter of Samuel Montagu, first Baron Swaythling, Liberal MP and founder of a merchant bank. Philip was educated at Clifton College, …

View Full Text

Log in

Log in through your institution


* For online subscription